Target intelligence / Profile preview

Tectonin beta-propeller repeat-containing protein 2 pre-messenger RNA (TECPR2 pre-mRNA) (TECPR2 pre-mRNA)

Target
TECPR2 pre-mRNA
Molecular classification
RNA, Pre-messenger RNA
01

Overview

TECPR2 pre-mRNA is the precursor messenger RNA transcript of the Tectonin beta-propeller repeat-containing protein 2 gene, which is essential for the regulation of autophagy and intracellular protein trafficking (Stadel et al., 2015). The resulting TECPR2 protein acts as a scaffold that facilitates the formation of autophagosomes by interacting with the COPII coat complex and ATG8 family proteins (Oz-Levi et al., 2012). Mutations in the TECPR2 gene, particularly those affecting the splicing of its pre-mRNA, are the primary cause of Hereditary Sensory and Autonomic Neuropathy type 9 (HSAN9), also known as Spastic Paraplegia 49 (SPG49). This rare neurodegenerative disorder is characterized by global developmental delay, autonomic instability, and progressive motor impairment. Therapeutic strategies targeting TECPR2 pre-mRNA utilize antisense oligonucleotides (ASOs) designed to modulate splicing, such as inducing the inclusion of exons that are skipped due to pathogenic mutations (Kim et al., 2019). By correcting the splicing of the pre-mRNA, these therapies aim to restore the production of functional TECPR2 protein and rescue autophagic flux in affected neurons. This approach represents a significant advancement in precision medicine for ultra-rare genetic conditions.

Other names
TECPR2 precursor mRNAKIAA0329 pre-mRNATectonin beta-propeller repeat-containing protein 2 transcript
02

Mechanism of action

Splice modulation to restore functional protein expression

03

Biological functions

AutophagyIntracellular protein transportCOPII-dependent transportAutophagosome maturation
04

Disease associations

Hereditary sensory and autonomic neuropathy type 9 (HSAN9)Spastic paraplegia 49 (SPG49)Neurodegenerative disease
05

Safety considerations

Off-target hybridizationInnate immune activationDelivery to the central nervous systemPotential for hepatotoxicity
06

Interacting drugs

Antisense oligonucleotides (ASOs)
07

Biomarkers

TECPR2 protein levelsLC3-II/LC3-I ratioAutophagic fluxp62/SQSTM1 accumulation

Beyond the preview

Go deeper on Tectonin beta-propeller repeat-containing protein 2 pre-messenger RNA (TECPR2 pre-mRNA) (TECPR2 pre-mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tectonin beta-propeller repeat-containing protein 2 pre-messenger RNA (TECPR2 pre-mRNA) (TECPR2 pre-mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call